A photoisomerizable muscarinic antagonist. Studies of binding and of conductance relaxations in frog heart
Abstract
These experiments employ the photoisomerizable compound, 3,3'-bis- [alpha-(trimethylammonium)methyl]azobenzene (Bis-Q), to study the response to muscarinic agents in frog myocardium. In homogenates from the heart, trans-Bis-Q blocks the binding of [3H]-N-methylscopolamine to muscarinic receptors. In voltage-clamped atrial trabeculae, trans- Bis-Q blocks the agonist-induced potassium conductance. The equilibrium dose-response curve for carbachol is shifted to the right, suggesting competitive blockade. Both the biochemical and electrophysiological data yield a dissociation constant of 4-5 microM for trans-Bis-Q; the cis configuration is severalfold less potent as a muscarinic blocker. Voltage-clamped preparations were exposed simultaneously to carbachol and Bis-Q and were subjected to appropriately filtered flashes (less than 1 ms duration) from a xenon flashlamp. Trans leads to cis and cis leads to trans photoisomerizations cause small (less than 20%) increases and decreases, respectively, in the agonist-induced current. The relaxation follows an S-shaped time course, including an initial delay or period of zero slope. The entire waveform is described by [1 - exp(-kt)]n. At 23 degrees C, k is approximately 3 s-1 and n is 2. Neither k nor n is affected when: (a) [Bis-Q] is varied between 5 and 100 microM; (b) [carbachol] is varied between 1 and 50 microM; (c) carbachol is replaced by other agonists (muscarine, acetylcholine, or acetyl-beta-methylcholine); or (d) the voltage is varied between the normal resting potential and a depolarization of 80 mV. However, in the range of 13-30 degrees C, k increases with temperature; the Q10 is between 2 and 2.5. In the same range, n does not change significantly. Like other investigators, we conclude that the activation kinetics of the muscarinic K+ conductance are not determined by ligand-receptor binding, but rather by a subsequent sequence of two (or more) steps with a high activation energy.
Additional Information
© 1982 by The Rockefeller University Press. RUP grants the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode. Received for publication 17 April 1981 and in revised form 12 September 1981. Supported by Research Career Development Award NS-272 to H.A.L. and grants NS-11756 and NS-15581 from the National Institutes of Health, a NATO fellowship to J.N., grant 78.7.2582 from the Délégation Générale à la Recherche Scientifique et Technique, the Pew Foundation, the Muscular Dystrophy Association, and grant PCM-77-19280 from the National Science Foundation.Attached Files
Published - NARjgp82.pdf
Files
Name | Size | Download all |
---|---|---|
md5:0e4b044f5db7ead36ad64d873be160aa
|
1.3 MB | Preview Download |
Additional details
- PMCID
- PMC2215484
- Eprint ID
- 12039
- Resolver ID
- CaltechAUTHORS:NARjgp82
- NIH
- NS-272
- NIH
- NS-11756
- NIH
- NS-15581
- North Atlantic Treaty Organization (NATO)
- Délégation Générale à la Recherche Scientifique et Technique
- Pew Foundation
- Muscular Dystrophy Association
- NSF
- PCM-77-19280
- Created
-
2008-10-21Created from EPrint's datestamp field
- Updated
-
2021-11-08Created from EPrint's last_modified field